For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.
TMS is used diagnostically to measure the connection between the brain and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease, and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.
Scope of the Report:
This report focuses on the Transcranial Magnetic Stimulators (TMS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Transcranial Magnetic Stimulators (TMS) is widely sales for Depression, Tinnitus, Alzheimer, Parkinson's Disease, Psychiatric Disorders, Headache, Stroke, etc. The most proportion of Transcranial Magnetic Stimulators (TMS) is used for Depression, and the consumption proportion is about 20% in 2017.
Europe is the largest supplier of Transcranial Magnetic Stimulators (TMS), with a production market share 38.5%. The second place is North America, following Europe with the production market share of 32%.
North America is the largest consumption place, with a consumption market share nearly 32.3% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.9%, China is also an important sales region for the Transcranial Magnetic Stimulators (TMS).
The worldwide market for Transcranial Magnetic Stimulators (TMS) is expected to grow at a CAGR of roughly 9.6% over the next five years, will reach 160 million US$ in 2023, from 90 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Dr. Langer Medical
- MAG & More
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Parkinson's Disease
- Psychiatric Disorders
There are 15 Chapters to deeply display the global Transcranial Magnetic Stimulators (TMS) market.
Chapter 1, to describe Transcranial Magnetic Stimulators (TMS) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Transcranial Magnetic Stimulators (TMS), with sales, revenue, and price of Transcranial Magnetic Stimulators (TMS), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Transcranial Magnetic Stimulators (TMS), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Transcranial Magnetic Stimulators (TMS) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Transcranial Magnetic Stimulators (TMS) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source